3PBIOVIAN
Heidi Suuronen currently serves as Group CFO at 3PBIOVIAN since February 2024 and has held the position of CFO and Deputy CEO at Biovian since May 2019, following an earlier role as CFO. Prior experience includes serving as Group Controller at HKScan Corporation from January 2008 to May 2019, where responsibilities encompassed group finance and control, management reporting, and financial structures. Earlier in the career, Heidi Suuronen worked at EY as a Group Financial Controller and Assistant Auditor from September 2004 to December 2007. Academic qualifications include a Master's degree in Accounting and Finance from the Turku School of Economics, completed in 2004.
This person is not in any teams
This person is not in any offices
3PBIOVIAN
3PBIOVIAN service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production, with the provision for fill and finish services for recombinant proteins and viral vectors. Leveraging a combined track record of 40 years in process development and analytical methods development, complemented by the experience in process scale-up, GMP manufacturing, and commercial supply, 3PBIOVIAN is equipped to offer comprehensive manufacturing services at all stages, encompassing Drug Substance and Drug Product. Manufacturing sites in Pamplona-Noáin, Spain, and Turku, Finland seamlessly support the diverse needs of clients, covering pre-clinical and clinical supply to full-scale commercial manufacturing.